Skip to content

Drug interactions

Inotuzumab + Tacrolimus

Severity: Major

Inotuzumab and Tacrolimus: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both agents are associated with QT prolongation, so combined use may increase the risk of torsade de pointes. Inotuzumab also carries hepatotoxicity and veno-occlusive disease risk, which complicates tacrolimus use after transplant.

What this interaction means in plain words

Inotuzumab and Tacrolimus can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Low

Why it happens

Additive prolongation of cardiac repolarization (QT interval).

What to do

Obtain a baseline ECG and repeat it during treatment, and keep potassium and magnesium within normal range. Consider alternatives if the QTc becomes markedly prolonged.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Inotuzumab and Tacrolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Inotuzumab with Tacrolimus?

MediHelp rates the interaction as major. Inotuzumab and Tacrolimus can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both agents are associated with QT prolongation, so combined use may increase the risk of torsade de pointes. Inotuzumab also carries hepatotoxicity and veno-occlusive disease risk, which complicates tacrolimus use after transplant.

How serious is the interaction between Inotuzumab and Tacrolimus?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and repeat it during treatment, and keep potassium and magnesium within normal range. Consider alternatives if the QTc becomes markedly prolonged.

What other medicines interact with Tacrolimus?

MediHelp also lists interactions of Tacrolimus with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Cidofovir. The full list is on the Tacrolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in